The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe (original) (raw)

Appendix A

Concerted action contract No BMH4-CT96-1543 (DG 12-SSMA) between The European Community represented by the Commission of the European Communities (‘the Commission’) represented by the Director General for DG XII Science, Research and Development, or its authorised representative, and Université Henri Poincaré Nancy I, (‘UNANCY.CM’) established in France (‘the Contractor’), represented by its authorised representative, have agreed to a concerted action called ‘Apolipoprotein E: Health and disease marker in Europe’.

The Contractor: Université Henri Poincaré (Nancy I), Centre du Médicament, Nancy France: Professor Gérard Siest and Dr Sophia Visvikis.

Members of the Steering Committee: Professor G Siest and Dr S Visvikis, Nancy as coordinators, and Professor A Evans, Belfast; G De Backer, Gent; Professor J Shepherd, Glasgow.

The ApoEurope group, collaborating centres, and their associated investigators: Belgium: Department of Public Health, University of Gent, Gent: Professor Guy De Backer*, Dr Dirk De Bacquer.

Croatia: Clinical Institute of Laboratory Diagnosis, Zagreb University School of Medicine and Clinical Hospital Centre, Zagreb: Professor Rukavina Ana Staljvenic,* Dr Jadranka Sertic, Dr Tomislav Babic and Dr Branka Ribaric.

Finland: National Public Health Institute, Department of Biochemistry, Helsinki: Professor Christian Ehnholm,* Veikko Salomaa; National Public Health Institute, Department of Epidemiology and Health Promotion, Helsinki: Professor Jaakko Tuomilehto; Research Institute of Public Health, University of Kuopio: Professor Jukka T Salonen.

France: Centre de Médecine Préventive, Vandoeuvre-les- Nancy: Professor Gérard Siest,* Dr Sophia Visvikis,* Dr Françoise Schiele, Dr Monique Vincent-Viry, Dr Bernard Herbeth, Dr Catherine Sass, Dr Aksam Merched, Dominique Aguillon, Mickael Maurice and the laboratory staff of the Centre; Institut National de la Santé et de la Recherche Médicale, Unité 258, Hôpital Broussais, Paris: Dr Laurence Tiret; Institut Pasteur de Lille, Lille: Professor Jean-Charles Fruchart, Dr Jean Dallongeville.

Germany: Medizinische Klinik, Universitäts-Krankenhaus Eppendorf, Hamburg: Dr Ulrike Beisiegel,* Central laboratory, University Hospital, Freiburg: Dr Winfried März.

Greece: The University of Crete, School of Medicine, Department of social Medicine, Heraklion: Professor Anthony Kafatos,* Dr Joanna Moschandreas.

Italy: Clinical Chemistry, Legnano Hospital, Legnano- Milano: Dr Paolo Brambilla,* IRCCS Ospedale San Raffaele, Clinical Molecular Biology Laboratory, Milano: Dr Maurizio Ferrari, Dr ssa Stefania Stenirri; Department of Neurology, Milano: Dr Massimo Franceschi; di Ricerca per le Malattie Cronico Degenerative, Università di Milano, Ospedale di Monza: Dr Marco Ferrari.

Macedonia: Clinic of Neurology, Faculty of Medicine, Skopje: Dr Angel Mitrevski.*

Portugal: Unidade de Quimica Clinica, Instituto Nacional de Saude, Lisbon: Dr Maria do Carmo Martins,* Maria Odete Rodrigues, Maria Isabel Albergaria, Maria Liseta Alpendre.

Spain: Programa Cronicat, Institute of Health Studies, Barcelona: Dr Susanna Sans,* Paluzie Guillem, Balanã Lluisa and Inãki Pérez; Unitat Recerca Lipids i Arteriosclerosi, Facultat de Medecina, Hospital de Sant Joan, Universitat Rovira i Virgili, Reus: Dr Luis Masana, Dr Josep Ribalta, Dr Pilar Dra Martinez, Dr Jose Maria Olive.

United Kingdom: Department of Epidemiology and Public Health, The Queen's University of Belfast, Belfast, Northern Ireland: Professor Alun Evans,* Dr John Yannell; Department of Medicine, The Queen's University of Belfast, Belfast, Northern Ireland: Dr D McMaster; Department of Pathological Biochemistry, Royal Infirmary, University of Glasgow, Glasgow, Great Britain: Professor James Shepherd.

Yugoslavia: Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade: Prof Marina Stojanov.*

*Principal investigator.